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There is a need for a fast and non-invasive tool to detect Pseudomonas aeruginosa airway colonisation in cystic fibrosis 
(CF) patients unable to expectorate. Fifty CF children and 19 controls aged 5-17 years were included in the feasibility study. 
A surface-enhanced Raman spectroscopy (SERS) nanochip optimised for detection of trace amounts of the P. aeruginosa 
biomarker hydrogen cyanide (HCN) was mounted inside a Tedlar bag, which the patient breathed into. The SERS chip was 
then analysed in a Raman spectrometer, investigating the C≡N peak at 2131 cm
-1
 and correlated with sputum cultures.
One new P. aeruginosa colonisation occurred during the trial period. The C≡N peak intensity was enhanced in this sample 
in contrast to the subject’s 3 other samples. Three additional patients had intense C≡N SERS signals from their breath, but 
no P. aeruginosa was cultured from their sputum. It is concluded that SERS spectroscopy can be developed into an easy to 
use hypersensitive clinical prescreening method for detection of HCN in human breath.
Introduction 
Pseudomonas aeruginosa airway infections are the major 
cause of morbidity and mortality in cystic fibrosis (CF) 
patients
1,2
. The methods that are being used in the CF clinic to
discover P. aeruginosa in non-expectorating children are 
invasive, because either a swab needs to enter through the 
mouth and into the pharynx or a tube is inserted through the 
nose and into the larynx to obtain a sample. Even with these 
procedures there is a low sensitivity, and it has been estimated 
that approximately 75% of all newly discovered P. aeruginosa 
infections are already persistently established
3
. Therefore,
there is an urgent need for a sensitive, fast, cheap and non-
invasive diagnostic tool to detect early P. aeruginosa airway 
colonisation in CF children who are unable to produce sputum 
or expectorate properly. P. aeruginosa emits the poisonous 
gas hydrogen cyanide (HCN), which can be an advantage 
combating other microorganisms in the lungs
4,5
. HCN is
considered a potential P. aeruginosa biomarker, and it was 
detected at median values of 13.5 ppb in children’s breath 
using selected ion flow tube mass spectroscopy (SIFT-MS)
4
. In
the SPACE study, Gilchrist and co-workers measured HCN in 
exhaled breath of CF children, also using SIFT-MS
6
. At present
time, SIFT-MS has not been optimized to meet the need for 
fast detection of bacteria, and the measurements were made 
after up to 24 hours, whereby some of the exhaled HCN may 
have been lost. Additionally, in the SPACE study, chronically 
infected patients were included, whose P. aeruginosa may 
have ceased producing HCN. Previously we have shown that at 
some point during adaptation P. aeruginosa can stop 
producing HCN, which can explain why the biomarker cannot 
be detected in the breath of all CF patients with a chronic 
airway infection
7
.
Between C and N of cyanide there is a triple bond, which gives 
rise to a distinct peak in a Raman spectrum at 2131 cm
-1
. 
Raman spectroscopy is a fast and non-invasive analytical 
technique extensively used for molecular fingerprinting. The 
technique identifies analytes by differentiating their molecular 
vibrational frequencies in the probed Raman scattering signal. 
However, the limit of detection for traditional Raman 
spectroscopy is in the range of millimolar concentration
8
, 
impeding the use of the technique for detecting molecules at 
lower concentrations. To indicate P. aeruginosa infection in 
the breath of patients with CF, detection levels of HCN below 
20 ppb are required
4
. As an advance of Raman spectroscopy,
surface-enhanced Raman spectroscopy (SERS) probes the 
enhanced Raman scattering signal from analytes sitting on the 
surface of noble metal nanostructures
9
. In addition, the affinity
of cyanide towards gold
10
 makes SERS very suitable for
detecting trace amount of HCN. Recently, we have 
demonstrated the fast identification and quantification of gas-
phase HCN down to 18 ppb on gold coated silicon nanopillar 
substrates
11
, which are manufactured in large-format by a cost
effective process
12
. We have also applied the SERS method to
detect HCN in emissions from P. aeruginosa cultures isolated 
from CF patients
7
. Our results indicate that SERS on the 
nanopillar substrate may have significant potential towards 
fast, cheap and non-invasive detection of P. aeruginosa lung 
colonisation from the breath of children with CF. In this 
feasibility study, we wanted to use the gold (Au)-coated silicon 
(Si) SERS substrate for direct detection of HCN in the breath of 
CF children with an early P. aeruginosa colonisation. 
Materials and Methods 
Subjects and study design 
Fifty children with CF (median age 11 years, range 5-17 years) 
and 19 non-CF, age-matched controls were included in the 
study. CF patients were excluded if their latest total IgG 
measured by an Enzyme-Linked-Immosorbent Assay (ELISA) 
against P. aeruginosa antigens was above 2.39 ELISA units, or if 
the number of precipitating antibodies against P. aeruginosa 
was ≥ 2, meaning that they had a chronic P. aeruginosa 
infection
13
, except from two CF patients who were included to
compare in vitro results
7
 to in vivo breath analysis. A total of
50 CF children were followed for four months at the CF centre 
at Rigshospitalet. Each month the child exhaled into a 3L 
Tedlar bag with the SERS substrate mounted inside, which was 
analysed a few hours later. The intensity of the cyanide peak at 
2131 cm
-1
 was compared to culture of sputum samples
obtained via expectoration or endo-laryngeal suction. 
The controls were patients and siblings seen in the CF 
outpatient clinic at Rigshospitalet during the study period, 
which was January-April 2016. Controls were not included if 
they had CF, primary cilia dyskinesia (PCD) or asthma. 
Enrolment took place during the entire study period, and each 
subject was tested between 1 and 5 times. Controls were only 
tested once. The controls only delivered breath and no sputum 
sample. 
The SERS substrate 
The disposable SERS substrate was fabricated on a single-side 
polished Si wafer using 3 min reactive ion etching (RIE) with 
alternating SF6 bombardment and O2 passivation for 
protection of the emerging nanopillars, followed by a 1 min O2 
plasma cleaning step. Up till 5 days prior to use, Au was 
evaporated onto the Si nanopillars, forming 225 nm caps used 
for SERS detection (Figure 1a). On the day of exposure the 
wafer was cut into 5x10 mm
2
 substrates using a diamond 
cutter and tweezers. The substrates were cleaned by 
immersion into ethanol (Absolute grade, CHROMASOLV R, 
Sigma-Aldrich, St. Louis, MO, USA) for 3 min followed by H2O 
(Molecular Biology Reagent grade, Sigma-Aldrich, St. Louis, 
MO, USA) for 3 min and left to dry on a tissue whereby the 
pillars would lean to enable SERS detection (Figure 1b). For 
easy handling and transportation the SERS substrate was 
mounted inside a small Petri dish, using double sided adhesive 
tape (Scotch), with a Post-It on top, the tacky side facing up for 
holding the substrate. The wall of the Petri dish protected the 
delicate SERS substrate so it would not get in contact with the 
Tedlar bag and be scratched (Figure 1c). 
The collection device 
Three L disposable Tedlar sample bags with polypropylene 
fittings (SKC, Pennsylvania, USA) were used for breath 
collection, with one large corner cut off, so the Petri dish 
containing the SERS substrate could be mounted inside (Figure 
1d). The bag was closed with a clamp (Scentroid, Ontario, 
Canada). Part of a disposable latex tube (Philips Respironics, 
Colorado, USA) was used to connect the inlet of the Tedlar bag 
to the PEP flutter (Intersurgical, Berkshire, UK) that the child 
would blow through, equipped with a 3.5 mm resistance 
(Wellspect Healthcare, Mölndal, Sweden). 
Sample collection 
The child filled the Tedlar bag with 1-5 deep exhalations. The 
bag was closed and left for 15 minutes before evacuation in a 
laminar air flow bench. The lid was put on the Petri dish, which 
was then secured tightly in a small zipper bag for 
transportation. A short questionnaire was also filled in, 
regarding present well-being, coffee intake and smoking, 
because it is known that these stimulants can influence the 
amount of HCN in the breath
14,15
. 
Raman measurements 
SERS measurements were recorded using an FT-Raman 
instrument (Bruker VERTEX 70, Bruker Optik, Ettlingen, 
Germany), equipped with a 1064 nm laser and an indium 
gallium arsenide  (InGaAs) detector. Samples were measured 
in a 180 degrees backscattering geometry using a laser power 
of 200 mW with 32 scans at a resolution of 4 cm
-1
. Each sample
was measured at 5 different positions on the substrate. 
Data analysis 
The five spectra obtained from different positions on the SERS 
substrate were averaged in order to increase the signal to 
noise ratio. The average per sample was subsequently pre-
processed using Standard Normal Variate (SNV)
16
. SNV
eliminates off-sets and slopes from spectra with similar 
spectral features aiding visual inspection as well as reducing 
complexity of later data analysis. Principal component analysis 
(PCA)
17
 was performed using the PLS_toolbox (Ver. 7.9.5,
Eigenvector Research, USA) in Matlab 2015a (MathWork, USA) 
on the pre-processed data both on the full spectral range and 
a reduced data set with only the HCN peak around 2131 cm
-1
.
In figures 2 and 3, the background was subtracted and spectra 
were shifted up for clarity. 
Ethical approval 
The local ethics’ committee approved the feasibility study, 
which was assigned the number H-15016027. Informed 
consent was obtained from the parents or from the children 
aged 15 years or older. 
Results 
Demographics 
A total of 50 CF patients and 19 controls were included in the 
study (Table 1). With 4 months and 50 CFs, about 2 new cases 
of P. aeruginosa colonisation were expected (according to the 
outcome of
6
), but a few patients with chronic infections were
included, leaving fewer naïve cases. 
Table 1. Demographics of included CF patients and controls 
CF patients 
Median age, years (range)  11 (5-17) 
Gender, number (%) Males 23 (46) Females 27 (54) 
No. of visits by CF patients in total: 87 
Controls 
Median age, years (range)  8 (5-17) 
Gender, number (%) Males 12  (63) Females 7 (37) 
No. of visits by the controls in total: 19 
Underlying diseases of the controls: Other phacomatoses, 
Secondary pulmonary condition, Cough, Pneumonia, Pulmonary 
atelectasis, Stridor, Pulmonary hemoptysis, Acute bronchitis. 
Comparison of in vitro and in vivo SERS 
Previously, in vitro SERS measurements were made on P. 
aeruginosa cultures isolated from chronically infected 
paediatric CF patients in the outpatient clinic
7
. Two of these
patients were also included in the study because their isolates 
represented two different trends in the in vitro study. In the in 
vitro study, all first (wild type-like) isolates emitted detectable 
HCN. After it had turned into a chronic infection, subject A had 
a lasR mutated P. aeruginosa isolate which still produced HCN 
(Figure 2a, red spectrum), while subject B’s lasR mutated P. 
aeruginosa isolate had turned off the expression of HCN 
(Figure 2b, red spectrum). Therefore, it was interesting to 
investigate whether this trend was also seen in vivo. The 
isolates were obtained five years before, so the bacteria could 
possibly have mutated further in the meantime. As seen in the 
figures’ blue spectra, no HCN was detected from their breath.  
Patient A: Both the wild type-like (green) and the lasR mutated 
isolate (red) emitted HCN, which can be seen from the intense 
C≡N peak at 2131 cm
-1
, whereas no HCN was detected from
the patients’ breath (blue). Patient B: The wild type-like isolate 
emitted HCN, which did neither the lasR mutated isolate, nor 
the breath sample. SERS on headspace of Luria Broth (LB) 
growth medium is included as reference (black). There is a 
background peak in the SERS spectra close to where the 
cyanide peak is located. 
Although chronically infected with P. aeruginosa, patient A 
only cultured Stenotrophomonas maltophilia and no P. 
aeruginosa from sputum, whereas patient B cultured both 
mucoid and non-mucoid P. aeruginosa. 
Four cases of elevated cyanide signal 
There was one new case of P. aeruginosa during the 4 months’ 
trial period. Patient C was a 15 year-old male with a positive 
sputum culture at his 3
rd
 out of 4 visits during the four months. 
Figure 3 shows the SERS spectra from his four visits, with a 
more intense triple bond signal about 2131 cm
-1
 from visit no.
3. Additionally, the red peak is slightly shifted towards higher
wave numbers, away from the background signal. After 
antibiotic eradication therapy between the third and fourth 
visit to the outpatient clinic, the background peak is back to 
where it started (green). The intensity is increased at visit no. 
3, and the peak is slightly shifted towards higher wave 
numbers. 
Three additional times during the trial period the SERS triple 
bond signal was elevated in breath samples,but none of these 
patients had P. aeruginosa cultured from their sputum. In one 
of the cases, the Tedlar bag had been left for 60 min before 
the SERS substrate was taken out, and it turned out that this 
had also been the case in the 3
rd
 visit of patient C, and it is
uncertain whether this had an effect on the peak intensity. 
Two of the incidents were from children whose parents were 
smoking in-door at home, which may have been detected on 
the chip. One of them cultured yeast, while the other only 
cultured non-pathogenic oropharyngeal microorganisms from 
the sputum samples. 
Discussion 
We explored whether the SERS chip could be used to detect 
the biomarker HCN in the breath of CF children with an early P. 
aeruginosa airway colonisation and whether our findings could 
be correlated to the findings in sputum cultures. Due to a 
limited number of includable patients, only one new case of P. 
aeruginosa was cultured during the study period, and it was 
most likely detected on the SERS chip. In the SERS 
measurements from the patient’s other visits, only the 
background peak was present. Three additional cases of 
intense CN signal occurred in children, whose sputum cultures 
were P. aeruginosa negative. There was a dependency of 
exposure time on peak intensity, and it seemed like passive 
smoking could also be detected from the children’s breath. 
The reason to include two patients with chronic infections was 
that we wanted to compare our in vitro results
7
 on their first
colonising strain and later lasR mutated isolate to in vivo 
breath analysis, because these cannot be expected to be the 
same
18
. Patient A, whose lasR mutated P. aeruginosa isolate
emitted HCN, was 8 years old; and at the time the strain was 
isolated she was 3. An explanation to why no HCN was 
detected in the breath of this patient could be that the 
bacteria had mutated even further since the isolate was 
cultured back in 2011. Even though this CF patient has about 
25 precipitating antibodies against P. aeruginosa today, no P. 
aeruginosa had been cultured from her last 3 sputum samples. 
Only when naso-laryngeal suction was performed, mucoid P. 
aeruginosa was cultured; and it can be questioned whether it 
came from the patient’s sinuses, and also whether young 
patients are able to expectorate properly.  
In the P. aeruginosa case cultured during the trial, the position 
of the Raman peak was not outside the normal shift seen 
across patients; however, the patient specific shift (assuming a 
given patient has an individual peak position) can be an 
indication. More similar cases are necessary to investigate or 
reject this hypothesis. Two of the 3 additional patients with 
positive cyanide SERS signal were children whose parents were 
smoking in-door at home. The third patient had an immediate 
microscopy result indicating few Gram-negative rods, but 
when the final microbiological result came, it was Moraxella 
catarrhalis, which is a diplococcus, that can hardly be mistaken 
for a Gram-negative rod. The question is, whether Gram-
negative rods were present in the beginning, but not cultured 
subsequently. Another observation was, that these children 
can be exposed to passive smoking as they enter the CF 
centre, which is located on the main floor, where people are 
standing right outside, smoking, because this is prohibited 
inside the hospital. 
A major drawback of the applied method is the background 
signal on the Au SERS substrate, which has also been reported 
elsewhere
21
, and it seems to be enhanced by the warm and
moist breath. The three cases with intense triple bond signal 
and negative sputum culture were followed for five months 
after study termination, and none of them cultured P. 
aeruginosa during the follow-up period, suggesting the SERS 
results must have been false positives. Regarding the control 
subjects, these need to be selected more carefully. Some were 
too sick, and some could have had P. aeruginosa in their lungs, 
since their sputum was not cultured. Ideally, the study period 
should have been longer or more patients should have been 
included to obtain more new positive P. aeruginosa cultures. 
In the SPACE study, Gilchrist and co-workers followed 233 CF 
children for 24 months, and 71 children cultured P. aeruginosa 
positive. With 50 CF children followed for 4 months, an 
estimate of two new P. aeruginosa cases were expected. To 
ease logistics and keep it to one centre, primary ciliary 
dyskinesia (PCD) patients could have been included, too, 
because it is known that the evolution of P. aeruginosa follows 
the same mutational steps in PCD as in CF
22
.
In the SPACE study, 21 chronically infected patients were 
included, who had not been cultured positive in their swab or 
sputum samples for the last 12 months
6
, and it can be 
questioned what the probability would be to culture positive 
during the trial period. In future studies we will suggest to 
consider using a more sensitive reference method, such as PCR 
instead of just sputum culture to detect whether P. aeruginosa 
is present in the sputum sample or not. Another issue 
regarding bacterial culturing is the transportation conditions of 
the sputum samples which could be optimised to better secure 
survival of the microorganisms. Samples should be either 
cooled down or kept at 37°C and transported immediately to 
the clinical microbiology laboratory and not wait up till 24 or 
48 hours due to internal mail delivery. The PCA analyses did 
not show strong trends in the pre-processed spectral data, and 
it is important to remember that the spectral measurements 
as well as the sputum culturing results carry large uncertainties 
due to exposure time differences, delayed analysis of sputum 
samples, possibly leading to increased number of false 
negative results, etc., making it challenging to relate the two. 
The CN peak intensity seemed to depend on exposure time, 
and in future studies the device could be left for e.g. 60 
minutes for complete exposure to occur. In the in vitro study, 
15 min exposure time was applied, which was sufficient, and it 
is a learning to take to the next clinical trial. Another way to 
overcome the exposure time issue could be to condensate the 
breath directly onto the SERS substrate. Disposable devices for 
this are available (like the R-Tube from MESM Ltd.)
19
, but it is
uncertain if patient compliance would be affected by having to 
breathe into a “chimney” device like this instead of into the 
applied “balloon-like” device which most of the children 
thought was fun. It could also be considered to make the 
substrate alkaline, so that a maximal amount of the cyanide 
would be expected to stay on the Au surface (according to 
Henry’s Law
20
).
Conclusions 
The present study, has demonstrated that Surface Enhanced 
Raman Spectroscopy (SERS) can be developed into a very 
useful and sensitive method for early detection of P. 
aeruginosa in CF patients. However, the method is highly 
sensitive to other sources of HCN wherefore more P. 
aeruginosa positive patients must be tested in future trials in 
order to prove whether this method can be used for diagnosis. 
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The SERS substrate. a) Scanning Electron Microscopy (SEM) image of the vertically standing nanopillars 
prior to leaning. The Si nanopillars are capped by gold, and the underlying Si substrate is covered by a gold 
film. b) Top-view SEM image of two clusters of nanopillars after leaning. c) Petri dish with a gold (Au) SERS 
substrate mounted inside. d) The filled collection device with the SERS chip inside, being exposed to exhaled 
breath. The tip of the PEP flutter is seen to the right. The fitting on top and the clamp at the bottom keep 
the Tedlar bag closed.  
In vitro and in vivo SERS on P. aeruginosa isolates and breath from two CF patients who today are 
chronically infected. Patient A: Both the wild type-like (green) and the lasR mutated isolate (red) emitted 
HCN, which can be seen from the intense C≡N peak at 2131 cm-1, whereas no HCN was detected from the 
patients’ breath (blue). Patient B: The wild type-like isolate emitted HCN, which did neither the lasR mutated 
isolate, nor the breath sample. SERS on headspace of Luria Broth (LB) growth medium is included as 
reference (black). There is a background peak in the SERS spectra close to where the cyanide peak is 
located.  
Zoom on the triple bond peak about 2131 cm-1 from patient C’s visits. The intensity is increased at visit no. 
3, and the peak is slightly shifted towards higher wave numbers.  
